Phio Pharmaceuticals Corp. (PHIOW) Stock Analysis

What Phio Pharmaceuticals Corp. does

Established in 2011 and headquartered in Marlborough, Massachusetts, Phio Pharmaceuticals Corp. is a biotechnology firm dedicated to advancing immuno-oncology treatments within the United States. Central to its approach is the proprietary INTASYL therapeutic platform, engineered to counteract the mechanisms by which tumors evade or suppress the body's natural immune response. Its pipeline features several promising candidates: PH-762 is designed to inhibit the PD-1 checkpoint protein found on immune cells, with development focused on applications in adoptive cell transfer (ACT). PH-804 targets TIGIT, another suppressive immune receptor and checkpoint protein present on both T cells and natural killer cells, also intended for ACT. PH-790 focuses on modulating the PD-L1 protein, which typically prevents immune cells from attacking healthy tissues. Phio Pharmaceuticals actively collaborates with leading institutions such as Gustave Roussy, Medigene AG, and Helmholtz Zentrum München. Furthermore, it maintains a strategic partnership with AgonOx Inc. specifically for the clinical advancement of innovative T cell-based immunotherapies for cancer. The company underwent a name change in November 2018, transitioning from its former identity as RXi Pharmaceuticals Corporation.

Key metrics

ETFs linked to PHIOW

Broad-market and Healthcare sector ETFs an investor holding Phio Pharmaceuticals Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PHIOW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Phio Pharmaceuticals Corp.?

Phio Pharmaceuticals Corp. trades under the ticker PHIOW on NASDAQ.

Which exchange is PHIOW listed on?

PHIOW is listed on NASDAQ.

What sector does Phio Pharmaceuticals Corp. operate in?

Phio Pharmaceuticals Corp. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PHIOW in a portfolio?

PortView shows PHIOW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.